Key Highlights
- MAX enters New York, Pennsylvania, and Vermont, marking significant growth in the Northeast.
- Targets 100% growth in 2024, aiming to broaden its reach in the Northeast and Mid-Atlantic.
- Supports 28 surgeons across 21 locations, emphasizing surgeon autonomy and clinical excellence.
Source: Business Wire
Notable Quotes
- “Our surgeons aren’t solely practitioners but collective disruptors in the oral surgery space — driving innovation and pushing boundaries supported by our partnership,” – Jason Auerbach, Co-CEO and Co-Founder at MAX
- “MAX’s growth and expansion show proof of their innovative approach, and the RF team is proud to support this pioneering group of oral surgeons,” – Peter Fidler, Co-Founder and Managing Partner at RF Investment Partners
SoHC's Take
The expansion of MAX Surgical Specialty Management into New York, Pennsylvania, and Vermont is a significant milestone that underscores the growing demand for specialized oral surgery services. This move, backed by strategic partnerships with RF Investment Partners and MedEquity Capital, not only strengthens MAX’s footprint in the Northeastern United States but also highlights the effectiveness of its physician-led model in promoting clinical autonomy and excellence. The targeted growth of approximately 100% in 2024 reflects MAX’s ambitious vision to revolutionize patient care in the oral surgery sector. By focusing on surgeon-led practices, MAX is poised to become a leading platform that prioritizes the quality of care and innovation. This approach not only benefits the surgeons and their practices but ultimately enhances the patient experience, setting a new standard in the healthcare industry.
